26 – 28 October, Shanghai, China
Organiser: Zheng-Hong Yuan (Ministries of Education and Public Health, Fudan University Shanghai Medical College, P. R. China)
Co-organiser: Alessandro Marcello (ICGEB Trieste, Italy)
Requests for information directly to: [email protected]
Deadline for receipt of applications by local organisers: 31 March 2018
CALL FOR APPLICATIONS NOW CLOSED
For information please contact the local organisers
The ICGEB aims at strengthening the research capability of its Members through a comprehensive training programme and approach to promoting biotechnology internationally. The active participation of ICGEB Member States nationals in the ICGEB Meetings and Courses is therefore highly encouraged. For more information on the terms of participation and funding opportunities for this event please access the meeting website or contact the local organisers directly.
RNA viruses are major threats to human health and cause sporadic, epidemic and pandemic outbreaks of lethal diseases worldwide Major pathogens include: HIV, influenza, HCV, SARS, MERS, Ebola, Dengue and Zika viruses. Although antiviral therapeutics for HIV and HCV are available, development of preventive vaccines is a major challenge due to rapid mutation of RNA viruses. Most other RNA virus infections do not have effective prevention and treatments. The objectives of the Workshop are to provide a platform for updates in prophylaxis and control of outbreaks for these infectious diseases and to explore novel strategies for vaccines, treatments and diagnosis by bringing together renowned international experts, scientists, clinicians and graduate students from ICGEB member states. The academic exchanges between basic scientists, clinicians, administrative officers, and individuals from industry may result in productive collaboration and quick translation from laboratories to clinical application, and will advance our understanding of molecular virology, transmission, immunologic responses and disease progression.
HCV basic virology and updates of new DAA treatments, novel therapies for HIV infection, emerging viral infection, arboviruses of concern, prophylactic and therapeutic updates, diagnosis.
Researchers involved in molecular virology, transmission, vaccination, diagnosis and therapeutic development. Public health administrators who oversee outbreaks and control measures for viral infections. Physicians who treat patients with acute or chronic viral infections. Graduate students who are engaged or interested in RNA viruses: from basic virology to clinical management.
A limited number of grants covering accommodation (twin share) and local hospitality for the duration of the course, are available to a selected number of nationals of ICGEB Member States. Priority will be given to applicants currently residing outside of China and submitting an abstract. The available grants will be allocated in order of priority, according to the ranking achieved in the selection process. Participants are expected to cover their own travel and living costs. Partial travel contribution may be available for a limited number of participants selected for abstract presentation.
Submit your application on-line by 31 March 2018.